Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-075644
Filing Date
2025-08-13
Accepted
2025-08-13 16:02:06
Documents
87
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0251467-10q_abvcbio.htm   iXBRL 10-Q 1539459
2 CERTIFICATION ea025146701ex31-1_abvcbio.htm EX-31.1 10291
3 CERTIFICATION ea025146701ex31-2_abvcbio.htm EX-31.2 10221
4 CERTIFICATION ea025146701ex32-1_abvcbio.htm EX-32.1 4632
5 CERTIFICATION ea025146701ex32-2_abvcbio.htm EX-32.2 4639
  Complete submission text file 0001213900-25-075644.txt   10097727

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE abvc-20250630.xsd EX-101.SCH 82247
7 XBRL CALCULATION FILE abvc-20250630_cal.xml EX-101.CAL 48885
8 XBRL DEFINITION FILE abvc-20250630_def.xml EX-101.DEF 454733
9 XBRL LABEL FILE abvc-20250630_lab.xml EX-101.LAB 771531
10 XBRL PRESENTATION FILE abvc-20250630_pre.xml EX-101.PRE 481292
90 EXTRACTED XBRL INSTANCE DOCUMENT ea0251467-10q_abvcbio_htm.xml XML 1308720
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40700 | Film No.: 251211343
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)